Schistosoma mansoni: stage-dependent damage after in vivo treatment with praziquantel
- PMID: 2107508
- DOI: 10.1017/s0031182000060121
Schistosoma mansoni: stage-dependent damage after in vivo treatment with praziquantel
Abstract
The in vivo effects of a single, subcurative dose (200 mg/kg body wt of mouse) of praziquantel on the structure of the tegument and subtegumental tissues of juvenile (21-, 26- and 30-day-old) and adult Schistosoma mansoni are described. In juvenile worms praziquantel caused only moderate damage to both the tegument and subtegumental tissues although the degree of drug-induced damage was related to both the sex of the worms and to the developmental status of each individual worm. In general, male worms exhibited more extensive and longer lasting surface damage than females. However, the level and extent of the changes increased as the worms became more developmentally advanced with adult worms showing extensive damage to the tegument and vacuolization and disruption of the subtegumental tissues. The possible correlation between the stage-dependent changes in susceptibility to praziquantel and age-related changes, particularly in the phospholipid composition of the outer tegumental membrane is discussed.
Similar articles
-
Schistosoma mansoni: structural damage and tegumental repair after in vivo treatment with praziquantel.Parasitology. 1987 Apr;94 ( Pt 2):243-54. doi: 10.1017/s0031182000053920. Parasitology. 1987. PMID: 3108831
-
Schistosoma mansoni: the effects of a subcurative dose of praziquantel on the ultrastructure of worms in vivo.Z Parasitenkd. 1983;69(1):73-90. doi: 10.1007/BF00934012. Z Parasitenkd. 1983. PMID: 6340360 Review.
-
Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.J Helminthol. 2002 Dec;76(4):327-33. doi: 10.1079/JOH2002135. J Helminthol. 2002. PMID: 12498638
-
Schistosoma japonicum and S. mansoni: ultrastructural damage in the tegument and reproductive organs after treatment with levo- and dextro-praziquantel.Am J Trop Med Hyg. 1989 Aug;41(2):204-11. doi: 10.4269/ajtmh.1989.41.204. Am J Trop Med Hyg. 1989. PMID: 2505625
-
Immune-dependent chemotherapy of schistosomiasis.Parasitology. 1992;105 Suppl:S41-8. doi: 10.1017/s003118200007534x. Parasitology. 1992. PMID: 1308928 Review.
Cited by
-
Microbial proteasomes as drug targets.PLoS Pathog. 2021 Dec 9;17(12):e1010058. doi: 10.1371/journal.ppat.1010058. eCollection 2021 Dec. PLoS Pathog. 2021. PMID: 34882737 Free PMC article. Review.
-
Schistosomiasis--a century searching for chemotherapeutic drugs.Parasitol Res. 2006 Oct;99(5):505-21. doi: 10.1007/s00436-006-0175-2. Epub 2006 Apr 25. Parasitol Res. 2006. PMID: 16636847 Review.
-
Evaluation of six novel antigens as potential biomarkers for the early immunodiagnosis of schistosomiasis.Parasit Vectors. 2015 Sep 4;8:447. doi: 10.1186/s13071-015-1048-2. Parasit Vectors. 2015. PMID: 26338369 Free PMC article.
-
Schistosomiasis drug therapy and treatment considerations.Drugs. 1991 Sep;42(3):379-405. doi: 10.2165/00003495-199142030-00004. Drugs. 1991. PMID: 1720380 Review.
-
Activity of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine against Schistosomiasis mansoni in mice.Antimicrob Agents Chemother. 2003 Dec;47(12):3853-8. doi: 10.1128/AAC.47.12.3853-3858.2003. Antimicrob Agents Chemother. 2003. PMID: 14638494 Free PMC article.